Teladoc Health, Inc. (TDOC)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Teladoc Health, Inc. reported revenue of $2.53B, down 1.5% from the prior year. The company ran a net loss, with a net margin of -7.9%. It held $2.86B in total assets against $1.47B in total liabilities.
Key ratios (FY2025)
-10.4%
Operating margin
-7.9%
Net margin
-14.5%
Return on equity
-1.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | — | — | — | — |
| Cost of Revenue | — | — | — | $743.99M | $650.26M | $390.83M | $184.47M | $128.74M | $61.62M | — |
| Gross Profit | — | — | — | — | — | — | — | $289.17M | $171.66M | $91.19M |
| Operating Income | -$262.95M | -$1.02B | -$248.55M | -$13.65B | -$265.63M | -$506.42M | -$80.44M | -$70.85M | -$75.39M | -$62.66M |
| Net Income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | -$428.79M | -$485.14M | -$98.86M | -$97.08M | -$106.78M | -$74.22M |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | — | — | — |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824.39M | $303.67M |
| Total Liabilities | $1.47B | $2.03B | $2.07B | — | — | — | — | — | — | — |
| Shareholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $558.90M | $230.87M |
| Cash & Equivalents | $781.08M | $1.30B | $1.12B | $918.18M | $893.48M | $733.32M | $514.35M | $423.99M | $42.82M | $50.02M |
| Operating Cash Flow | $294.36M | $293.68M | $350.02M | $189.29M | $193.99M | -$53.51M | $29.87M | -$4.86M | -$34.44M | -$51.88M |
| Capital Expenditures | $8.89M | $10.79M | $11.46M | $16.48M | $8.53M | $4.02M | $3.51M | $4.01M | $2.63M | $2.11M |
| Shares Outstanding | 178.32M | 173.41M | 166.66M | 162.84M | 160.47M | 150.28M | 72.76M | 70.52M | 61.53M | 46.20M |